pe
pep-05271 v1 CC-BY-SA-4.0

Waprin-Phi2 anticancer peptide

An experimental peptide being studied for its ability to fight cancer cells; not an approved drug.

statusbioassayed targetANTICANCER length52 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.734
avg pLDDT66.7
ranking score0.681
STRUCTURE · PEP-05271 × ANTICANCER
ranking0.681
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence52 aa
1510152025303540455052
EQEKPGSCPNVDM PIPPLGLCKTTCS KDSDCSETKKCCK NGCGFMTCTTARP
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.6806601881980896 boltz-2
3-letter notation
Glu-Gln-Glu-Lys-Pro-Gly-Ser-Cys-Pro-Asn-Val-Asp-Met-Pro-Ile-Pro-Pro-Leu-Gly-Leu-Cys-Lys-Thr-Thr-Cys-Ser-Lys-Asp-Ser-Asp-Cys-Ser-Glu-Thr-Lys-Lys-Cys-Cys-Lys-Asn-Gly-Cys-Gly-Phe-Met-Thr-Cys-Thr-Thr-Ala-Arg-Pro
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Waprin-Phi2 anticancer peptide (pep-05271, v1). PeptideModel. https://peptidemodel.com/card/pep-05271
@peptide{pep05271,
  sequence = {EQEKPGSCPNVDMPIPPLGLCKTTCSKDSDCSETKKCCKNGCGFMTCTTARP},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use